1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Circulating Tumor Cell (CTC) Diagnostics Market – By Technology

1.3.2        North America Circulating Tumor Cell (CTC) Diagnostics Market – By Application

1.3.3        North America Circulating Tumor Cell (CTC) Diagnostics Market – By End-User

1.3.4        North America Circulating Tumor Cell (CTC) Diagnostics Market – By Geography

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Circulating Tumor Cell (CTC) Diagnostics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        North America PEST Analysis

4.3         Experts Opinion

5.           Circulating Tumor Cell (CTC) Diagnostics Market– Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Cancer

5.1.2        Rising Demand for Minimally Invasive Diagnostic Procedures

5.2         Market Restraints

5.2.1        Dearth of Skilled Professionals Performing Diagnostic Procedures

5.3         Market Opportunities

5.3.1        Untapped Potential of Emerging Economies

5.4         Future Trends

5.4.1        Technological Advancements in Isolation of Circulating Tumor Cell

5.5         Impact Analysis

6.           Circulating Tumor Cell (CTC) Diagnostics Market– North America Analysis

6.1         North America Circulating Tumor Cell (CTC) Diagnostics Market Revenue Forecast and Analysis

6.2         Market Positioning of Key Players

7.           Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 – Technology

7.1         Overview

7.2         North America Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2020 & 2028 (%)

7.3         CTC detection and Enrichment Method

7.3.1        Overview

7.3.2        CTC Detection and Enrichment Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

7.4         CTC Direct Detection Method

7.4.1        Overview

7.4.2        CTC Direct Detection Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

7.5         CTC Analysis

7.5.1        Overview

7.5.2        CTC Analysis: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.           Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 – Application

8.1         Overview

8.2         North America Circulating Tumor Cell (CTC) Diagnostics Market Share, By Application - 2020 & 2028 (%)

8.3         Clinical/Liquid Biopsy

8.3.1        Overview

8.3.2        Clinical/Liquid Biopsy: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.3        Risk Assessment

8.3.3.1          Overview

8.3.3.2          Risk Assessment: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.4        Screening and Monitoring

8.3.4.1          Overview

8.3.4.2          Screening and Monitoring: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4         Research

8.4.1        Overview

8.4.2        Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4.2.1          Cancer Stem Cell & Tumorigenesis Research

8.4.2.1.1          Overview

8.4.2.1.2          Cancer Stem Cell & Tumorigenesis Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4.2.2          Drug/Therapy Development

8.4.2.2.1          Overview

8.4.2.2.2          Drug/Therapy Development: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.           Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 – End user

9.1         Overview

9.2         North America Circulating Tumor Cell (CTC) Diagnostics Market Share by End user - 2020 & 2028 (%)

9.3         Hospitals and Clinics

9.3.1        Overview

9.3.2        Hospitals and Clinics: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.4         Research and Academic Institutes

9.4.1        Overview

9.4.2        Research and Academic Institutes: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.5         Diagnostic Centers

9.5.1        Overview

9.5.2        Diagnostic Centers: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.        North America Circulating Tumor Cell (CTC) Diagnostics Market – Geographic Analysis

10.1      North America: Circulating Tumor Cell (CTC) Diagnostics Market

10.1.1     Overview

10.1.2     North America: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3     North America: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2019–2028 (US$ Million)

10.1.4     North America: Circulating Tumor Cell (CTC) Diagnostics Market, by Application, 2019–2028 (US$ Million)

10.1.4.1       North America Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)

10.1.4.2       North America Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)

10.1.5     North America: Circulating Tumor Cell (CTC) Diagnostics Market, by End User, 2019–2028 (US$ Million)

10.1.6     North America: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)

10.1.6.1       US: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.1       Overview

10.1.6.1.2       US: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.3       US: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2019–2028 (US$ Million)

10.1.6.1.4       US: Circulating Tumor Cell (CTC) Diagnostics Market, by Application, 2019–2028 (US$ Million)

10.1.6.1.4.1     US Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)

10.1.6.1.4.2     US Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)

10.1.6.1.5       US: Circulating Tumor Cell (CTC) Diagnostics Market, by End User, 2019–2028 (US$ Million)

10.1.7     Canada: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.7.1.1       Overview

10.1.7.1.2       Canada: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.7.1.3       Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2019–2028 (US$ Million)

10.1.7.1.4       Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Application, 2019–2028 (US$ Million)

10.1.7.1.4.1     Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)

10.1.7.1.4.2     Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)

10.1.7.1.5       Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by End User, 2019–2028 (US$ Million)

10.1.7.2       Mexico: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.7.2.1       Overview

10.1.7.2.2       Mexico: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.7.2.3       Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2019–2028 (US$ Million)

10.1.7.2.4       Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Application, 2019–2028 (US$ Million)

10.1.7.2.4.1     Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)

10.1.7.2.4.2     Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)

10.1.7.2.5       Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by End User, 2019–2028 (US$ Million)

11.        Impact of COVID-19 Pandemic on North America Circulating Tumor Cell (CTC) Diagnostics Market

11.1      North America: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1      Overview

12.2      Growth Strategies in the Circulating Tumor Cell (CTC) Diagnostics Market (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1      THERMO FISHER SCIENTIFIC INC.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      STEMCELL Technologies Inc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      QIAGEN

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Precision Medicine Group, LLC.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      ADVANCED CELL DIAGNOSTICS, INC. (BIO-TECHNE CORPORATION)

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      EPIC SCIENCES, INC.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      SCREENCELL

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      IKONISYS, INC.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      IVDiagnostics

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   FLUXION BIOSCIENCES

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             North America Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 2.             North America Circulating Tumor Cell (CTC) Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 3.             North America Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 4.             North America Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Clinical/ Liquid Biopsy Application (US$ Million)

Table 5.             North America Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 , by End User (US$ Million)

Table 6.             US Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 7.             US Circulating Tumor Cell (CTC) Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 8.             US Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 9.             US Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Clinical/ Liquid Biopsy Application (US$ Million)

Table 10.          US Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 , by End User (US$ Million)

Table 11.          Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Canada Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 13.          Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Canada: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Clinical/ Liquid Biopsy Application (US$ Million)

Table 15.          Canada Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 , by End User (US$ Million)

Table 16.          Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Mexico Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 18.          Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 19.          Mexico: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Clinical/ Liquid Biopsy Application (US$ Million)

Table 20.          Mexico Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 , by End User (US$ Million)

Table 21.          Organic Developments in the Circulating Tumor Cell (CTC) Diagnostics Market

Table 22.          Inorganic Developments in the Circulating Tumor Cell (CTC) Diagnostics Market

Table 23.          Glossary of Terms, Circulating Tumor Cell (CTC) Diagnostics Market

LIST OF FIGURES

Figure 1.           Circulating Tumor Cell (CTC) Diagnostics Market Segmentation

Figure 2.           North America Circulating Tumor Cell (CTC) Diagnostics Market Overview

Figure 3.           CTC detection and Enrichment Method Held Largest Share of Technology Segment in Circulating Tumor Cell (CTC) Diagnostics Market

Figure 4.           US is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           North America Circulating Tumor Cell (CTC) Diagnostics Market, Industry Landscape

Figure 6.           North America: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           North America Circulating Tumor Cell (CTC) Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

Figure 9.           Market Positioning of Key Players in North America Circulating Tumor Cell (CTC) Diagnostics Market

Figure 10.        North America Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2020 & 2028 (%)

Figure 11.        CTC Detection and Enrichment Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        CTC Direct Detection Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        CTC Analysis: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        North America Circulating Tumor Cell (CTC) Diagnostics Market Share, by Application - 2020 & 2028 (%)

Figure 15.        Clinical/Liquid Biopsy: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Risk Assessment: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Screening and Monitoring: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Cancer Stem Cell & Tumorigenesis Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Drug/Therapy Development: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 21.        North America Circulating Tumor Cell (CTC) Diagnostics Market Share by End user - 2020 & 2028 (%)

Figure 22.        Hospitals and Clinics: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Research and Academic Institutes: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Diagnostic Centers: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 25.        North America: Circulating Tumor Cell (CTC) Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 26.        North America Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 27.        North America: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 28.        US: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Canada: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Mexico: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Impact of COVID-19 Pandemic in North American Country Markets

Figure 32.        Growth Strategies in the Circulating Tumor Cell (CTC) Diagnostics Market (%)